Contineum Therapeutics (CTNM) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for Contineum Therapeutics (CTNM).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | 50M | - |
Operating Expenses | |||||||||||||
Research And Development | 12M (-8.70%) | 13M (+16.11%) | 11M (-21.83%) | 14M (+2.55%) | 14M (+5.30%) | 13M (+33.81%) | 9.73M (+23.16%) | 7.90M (+1.54%) | 7.78M (-2.87%) | 8.01M (+23.23%) | 6.50M (-31.29%) | 9.46M (+160.61%) | 3.63M |
Selling General And Administrative | 5.26M (+20.64%) | 4.36M (+10.66%) | 3.94M (+2.60%) | 3.84M (-12.73%) | 4.40M (+9.18%) | 4.03M (+24.00%) | 3.25M (+6.91%) | 3.04M (+41.40%) | 2.15M (+29.52%) | 1.66M (+5.73%) | 1.57M (-1.88%) | 1.60M (+8.11%) | 1.48M |
Operating Expenses | 17M (-1.23%) | 17M (+14.60%) | 15M (-16.59%) | 18M (-1.16%) | 18M (+6.22%) | 17M (+31.46%) | 13M (+18.56%) | 11M (+10.17%) | 9.93M (+2.58%) | 9.68M (+19.95%) | 8.07M (-27.03%) | 11M (+116.02%) | 5.12M |
Depreciation And Amortization | 80K (-68.00%) | 250K | - | - | 80K (-60.00%) | 200K | - | - | 60K (-50.00%) | 120K | - | - | 70K |
Operating Income | |||||||||||||
Operating Income | -16.90M (-1.23%) | -17.11M (+14.60%) | -14.93M (-16.59%) | -17.90M (-1.16%) | -18.11M (+6.22%) | -17.05M (+31.46%) | -12.97M (+18.56%) | -10.94M (+10.17%) | -9.93M (+2.58%) | -9.68M (+19.95%) | -8.07M | 39M | -5.11M |
Ebit | -16.90M (-1.23%) | -17.11M (+14.60%) | -14.93M (-16.59%) | -17.90M (-1.16%) | -18.11M (+6.22%) | -17.05M (+31.46%) | -12.97M (+18.56%) | -10.94M (+10.17%) | -9.93M (+2.58%) | -9.68M (+19.95%) | -8.07M | 39M | -5.11M |
EBITDA | -16.82M (-19.41%) | -20.87M (+63.17%) | -12.79M (-20.26%) | -16.04M (-11.04%) | -18.03M (-16.10%) | -21.49M (+109.25%) | -10.27M (+13.98%) | -9.01M (-8.71%) | -9.87M (-32.99%) | -14.73M (+131.24%) | -6.37M | 42M | -5.04M |
Other Income / Expenses | |||||||||||||
Interest Income | 2.51M (+24.88%) | 2.01M (+2.55%) | 1.96M (-3.45%) | 2.03M (-9.78%) | 2.25M (-11.07%) | 2.53M (-7.66%) | 2.74M (+37.00%) | 2.00M (+21.95%) | 1.64M (-8.38%) | 1.79M (+2.87%) | 1.74M (+155.88%) | 680K (+70.00%) | 400K |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | 120K (+33.33%) | 90K |
Net Interest Income | 2.51M (+24.88%) | 2.01M (+2.55%) | 1.96M (-3.45%) | 2.03M (-9.78%) | 2.25M (-11.07%) | 2.53M (-7.66%) | 2.74M (+37.00%) | 2.00M (+21.95%) | 1.64M (-8.38%) | 1.79M (+2.87%) | 1.74M (+155.88%) | 680K (+70.00%) | 400K |
Other Non Operating Income | -60.00K (-62.50%) | -160.00K | 180K | -170.00K (+30.77%) | -130.00K (-18.75%) | -160.00K (+433.33%) | -30.00K (-62.50%) | -80.00K (+700.00%) | -10.00K (-94.44%) | -180.00K (+350.00%) | -40.00K (-50.00%) | -80.00K (+300.00%) | -20.00K |
Net Income | |||||||||||||
Income Before Tax | - | -60.14M | - | - | - | -14.56M (+41.77%) | -10.27M (+13.98%) | -9.01M (+7.01%) | -8.42M (+6.18%) | -7.93M (+24.49%) | -6.37M | 42M | -4.82M |
Income Tax Expense | - | - | - | - | - | - | - | - | - | -160.00K (+33.33%) | -120.00K | 730K | - |
Net Income From Continuing Operations | -14.46M (-4.62%) | -15.16M (+18.53%) | -12.79M (-20.26%) | -16.04M (+0.31%) | -15.99M (+9.82%) | -14.56M (+41.77%) | -10.27M (+13.98%) | -9.01M (+7.01%) | -8.42M (+8.37%) | -7.77M (+24.32%) | -6.25M | 42M | -4.82M |
Net Income | -14.46M (-4.62%) | -15.16M (+18.53%) | -12.79M (-20.26%) | -16.04M (+0.31%) | -15.99M (+9.82%) | -14.56M (+41.77%) | -10.27M (+13.98%) | -9.01M (+7.01%) | -8.42M (+8.37%) | -7.77M (+24.32%) | -6.25M | 42M | -4.82M |
Comprehensive Income Net Of Tax | -14.97M (-74.96%) | -59.79M (+371.90%) | -12.67M (-21.11%) | -16.06M (+1.07%) | -15.89M (-62.43%) | -42.29M (+341.44%) | -9.58M (+5.51%) | -9.08M (+5.83%) | -8.58M | 23M | -6.27M | 42M | -4.76M |